Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amino acid metabolic enzymes represent a diverse superfamily of protein-based biological catalysts that orchestrate the transformation of the 20 standard amino acids through various biosynthetic and catabolic pathways. These enzymes are primarily localized in mitochondria, where they facilitate critical metabolic processes linking amino acid metabolism to central energy metabolism[2]. The enzymes possess characteristic structural features including a central carbon atom coordination and specific active sites formed by unique three-dimensional arrangements of amino acid residues. The active site represents a groove or crevice where substrates bind to facilitate catalyzed chemical reactions, typically occupying a small portion of the entire enzyme structure[7]. Functionally, these enzymes are classified into six major categories based on reaction type: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases[7]. Many require cofactors for activity, existing as inactive apoenzymes that become catalytically active holoenzymes upon cofactor binding. Cofactors include both inorganic metal ions (Mn, Zn, Fe, Cu) and organic coenzymes[7]. From a metabolic perspective, amino acid metabolic enzymes serve dual catabolic and anabolic functions. They catalyze the breakdown of amino acids for energy production through deamination and subsequent entry into the TCA cycle, while simultaneously facilitating the biosynthesis of non-essential amino acids from TCA cycle intermediates. The components of the TCA cycle serve as precursors for the synthesis of non-essential amino acids, which account for more than 50% of protein carbon[2]. These enzymes exhibit remarkable substrate specificity determined by the conformation of amino acids in their active sites, which stabilizes specific substrate binding. The degradation of branched-chain amino acids (valine, leucine, isoleucine) occurs predominantly in mitochondria through enzyme-catalyzed reactions, with only the first transamination step occurring in the cytoplasm[2]. Beyond energy metabolism, amino acid metabolic enzymes regulate gene expression, post-translational protein modifications, and cell fate determination by producing signaling metabolites[2]. They also maintain nitrogen balance through the urea cycle, converting toxic ammonia to excretable urea[6][8]. The therapeutic relevance of this enzyme family stems from their involvement in numerous metabolic diseases and their potential as drug targets in cancer, where altered amino acid metabolism supports malignant cell proliferation. Dietary modulation of amino acid availability has been shown to affect lifespan and health in model organisms through changes in mitochondrial biogenesis, antioxidant response, and respiratory chain activity[2].
Drugs and therapeutic interventions targeting amino acid metabolic enzymes work through several mechanisms: Competitive Inhibition (small molecules compete with natural substrates at the enzyme active site); Cofactor Modulation (providing or enhancing cofactors that activate apoenzymes to form functional holoenzymes); Allosteric Regulation (compounds bind to sites distinct from the active site to modulate enzyme activity); Substrate Channeling (modulating the availability of amino acid substrates to control metabolic flux); Transamination Modulation (targeting aminotransferases that mediate deamination and transfer amino groups to α-ketoglutaric acid to form glutamate).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amino acid metabolic enzymes (None - this is a broad category encompassing multiple distinct enzymes).